2022 Transferred values declared to VVKT

Transferred values

2022 Disclosing Reports for transfered values

AbbVie, UAB

2023-06-27

AstraZeneca Lietuva, UAB

2023-06-19

Bayer, UAB

2023-06-19

Biogen Lithuania, UAB

2023-06-29

Boehringer Ingelheim RCV GmbH & Co KG Lietuvos filialas

2023-06-30

Egis Pharmaceuticals PLC atstovybė Lietuvoje

2023-06-30

Eli Lilly Lietuva, UAB

2023-07-03

Grindeks, AB filialas

2023-07-03

Medochemie, UAB

2023-06-28

Merck Serono, UAB

2023-06-30

Merck Sharp & Dohme, UAB

2023-06-30

Mylan Healthcare, UAB

2023-07-11

Novo Nordisk Pharma, UAB

2023-06-26

Pfizer Luxembourg SARL filialas

2023-07-05

Servier Pharma, UAB

2023-06-19

Takeda, UAB

2023-06-28

Companies that had no transferred values during year 2022

Gedeon Richter Plc. atstovybė Lietuvoje

Zentiva Group, a.s. Lietuvos filialas

Disclosure reports of 2023 transfers of value

Disclosure reports of 2021 transfers of value

Disclosure reports of 2020 transfers of value

Disclosure reports of 2019 transfers of value

Disclosure reports of 2018 transfers of value

Disclosure reports of 2017 transfers of value

Disclosure reports of 2016 transfers of value

Disclosure reports of 2015 transfers of value